Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV005001141 | SCV005627293 | likely benign | Hereditary thrombocytopenia and hematologic cancer predisposition syndrome | 2025-01-15 | reviewed by expert panel | curation | NM_001754.5(RUNX1):c.508+6T>C is an intronic variant not predicted to affect splicing (BP4). This variant has a SpliceAI score ≤ 0.20 (0.14) and evolutionary conservation prediction algorithms predict the site as not being conserved (PhyloP score ≤ 2.0 (0.836)) (BP7). This variant is not present in any population databases (PM2_Supporting). In summary, the clinical significance of this variant is Likely benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BP4, BP7 |
Labcorp Genetics |
RCV001049190 | SCV001213229 | likely benign | Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 | 2023-10-13 | criteria provided, single submitter | clinical testing |